vs
AVADEL PHARMACEUTICALS PLC（AVDL）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是AVADEL PHARMACEUTICALS PLC的1.2倍（$94.3M vs $77.5M），REPUBLIC BANCORP INC净利率更高（24.2% vs 0.0%，领先24.2%），AVADEL PHARMACEUTICALS PLC同比增速更快（54.9% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $22.2M），过去两年AVADEL PHARMACEUTICALS PLC的营收复合增速更高（99.6% vs -11.5%）
Avadel Pharmaceuticals是爱尔兰的专科制药企业，专注于睡眠障碍治疗药物的研发，产品覆盖医院及基层医疗场景，总部位于爱尔兰都柏林，在美国密苏里州圣路易斯、法国里昂均设有业务运营点。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
AVDL vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.2倍
$77.5M
营收增速更快
AVDL
高出49.5%
5.3%
净利率更高
RBCAA
高出24.2%
0.0%
自由现金流更多
RBCAA
多$138.9M
$22.2M
两年增速更快
AVDL
近两年复合增速
-11.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.5M | $94.3M |
| 净利润 | $20.0K | $22.8M |
| 毛利率 | — | — |
| 营业利润率 | 2.5% | 29.3% |
| 净利率 | 0.0% | 24.2% |
| 营收同比 | 54.9% | 5.3% |
| 净利润同比 | 100.8% | 20.0% |
| 每股收益（稀释后） | $0.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVDLRBCAA
| Q4 25 | — | $94.3M | ||
| Q3 25 | $77.5M | $93.5M | ||
| Q2 25 | $68.1M | $93.8M | ||
| Q1 25 | $52.5M | $135.8M | ||
| Q4 24 | $50.4M | $89.5M | ||
| Q3 24 | $50.0M | $88.1M | ||
| Q2 24 | $41.5M | $86.9M | ||
| Q1 24 | $27.2M | $120.3M |
净利润AVDLRBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $20.0K | $29.7M | ||
| Q2 25 | $9.7M | $31.5M | ||
| Q1 25 | $-4.9M | $47.3M | ||
| Q4 24 | $-5.0M | $19.0M | ||
| Q3 24 | $-2.6M | $26.5M | ||
| Q2 24 | $-13.8M | $25.2M | ||
| Q1 24 | $-27.3M | $30.6M |
毛利率AVDLRBCAA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 90.7% | — | ||
| Q1 25 | 89.4% | — | ||
| Q4 24 | 90.5% | — | ||
| Q3 24 | 87.7% | — | ||
| Q2 24 | 93.3% | — | ||
| Q1 24 | 94.4% | — |
营业利润率AVDLRBCAA
| Q4 25 | — | 29.3% | ||
| Q3 25 | 2.5% | 40.4% | ||
| Q2 25 | 13.0% | 43.0% | ||
| Q1 25 | -5.7% | 44.1% | ||
| Q4 24 | -6.5% | 25.8% | ||
| Q3 24 | -0.7% | 38.4% | ||
| Q2 24 | -30.7% | 37.0% | ||
| Q1 24 | -95.8% | 32.2% |
净利率AVDLRBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | 0.0% | 31.8% | ||
| Q2 25 | 14.2% | 33.5% | ||
| Q1 25 | -9.4% | 34.8% | ||
| Q4 24 | -10.0% | 21.2% | ||
| Q3 24 | -5.2% | 30.1% | ||
| Q2 24 | -33.3% | 29.0% | ||
| Q1 24 | -100.6% | 25.4% |
每股收益（稀释后）AVDLRBCAA
| Q4 25 | — | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $0.10 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $-0.14 | — | ||
| Q1 24 | $-0.30 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $91.6M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $98.2M | $1.1B |
| 总资产 | $199.4M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AVDLRBCAA
| Q4 25 | — | $220.0M | ||
| Q3 25 | $91.6M | $484.2M | ||
| Q2 25 | $81.5M | $484.8M | ||
| Q1 25 | $66.5M | $793.0M | ||
| Q4 24 | $73.8M | $432.2M | ||
| Q3 24 | $65.8M | $530.9M | ||
| Q2 24 | $71.4M | $400.1M | ||
| Q1 24 | $88.8M | $546.4M |
股东权益AVDLRBCAA
| Q4 25 | — | $1.1B | ||
| Q3 25 | $98.2M | $1.1B | ||
| Q2 25 | $90.7M | $1.1B | ||
| Q1 25 | $74.1M | $1.0B | ||
| Q4 24 | $73.8M | $992.0M | ||
| Q3 24 | $74.7M | $979.7M | ||
| Q2 24 | $70.3M | $955.4M | ||
| Q1 24 | $78.4M | $935.6M |
总资产AVDLRBCAA
| Q4 25 | — | $7.0B | ||
| Q3 25 | $199.4M | $7.0B | ||
| Q2 25 | $187.2M | $7.0B | ||
| Q1 25 | $167.9M | $7.1B | ||
| Q4 24 | $164.2M | $6.8B | ||
| Q3 24 | $158.3M | $6.7B | ||
| Q2 24 | $157.5M | $6.6B | ||
| Q1 24 | $167.9M | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.2M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $22.2M | $161.1M |
| 自由现金流率自由现金流/营收 | 28.7% | 170.9% |
| 资本支出强度资本支出/营收 | 0.0% | 7.5% |
| 现金转化率经营现金流/净利润 | 1110.25× | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流AVDLRBCAA
| Q4 25 | — | $168.2M | ||
| Q3 25 | $22.2M | $33.3M | ||
| Q2 25 | $12.7M | $8.4M | ||
| Q1 25 | $-8.2M | $93.2M | ||
| Q4 24 | $7.9M | $149.0M | ||
| Q3 24 | $-6.9M | $51.3M | ||
| Q2 24 | $-18.2M | $4.0M | ||
| Q1 24 | $-29.7M | $71.2M |
自由现金流AVDLRBCAA
| Q4 25 | — | $161.1M | ||
| Q3 25 | $22.2M | $30.8M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | — | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率AVDLRBCAA
| Q4 25 | — | 170.9% | ||
| Q3 25 | 28.7% | 32.9% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | — | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度AVDLRBCAA
| Q4 25 | — | 7.5% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% |
现金转化率AVDLRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | 1110.25× | 1.12× | ||
| Q2 25 | 1.31× | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
